Audrey Laroche-Clary

Title: The Innovative Contributions of Audrey Laroche-Clary

Introduction

Audrey Laroche-Clary is a notable inventor based in Bordeaux, France. She has made significant strides in the field of medicine, particularly in cancer treatment. Her innovative approach to utilizing efavirenz has opened new avenues for therapeutic applications.

Latest Patents

Audrey holds a patent for an invention titled "Increased dosage of efavirenz for the treatment of cancer." This invention is based on the discovery that a higher daily dose of efavirenz can be effective in treating cancer, as opposed to the dosage typically used for AIDS treatment. The patent details the administration of efavirenz at a dose that generates a plasma concentration exceeding 3000 ng/ml. Specifically, it outlines a daily dose of at least 1800 mg, ideally between 1800 and 2200 mg. Furthermore, the invention includes a unique dosage form of efavirenz, which comprises a pharmaceutically acceptable carrier.

Career Highlights

Audrey is currently associated with Alienor Farma, where she continues to develop her innovative ideas. Her work has been instrumental in advancing the understanding of efavirenz's potential in oncology. With a patent count of 1 patent, her contributions are noteworthy in the medical field.

Collaborations

Audrey collaborates with esteemed colleagues such as Pier Vincenzo Piazza and Nadine Houede. Their combined expertise enhances the research and development efforts at Alienor Farma.

Conclusion

Audrey Laroche-Clary's innovative work in the application of efavirenz for cancer treatment exemplifies the impact of research and invention in medicine. Her contributions are paving the way for new therapeutic strategies that could benefit many patients.